The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Diabetes

• Publication date

  2002-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIABETES.51.2.514PMID 11812763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of Poly(ADP-ribose) Polymerase Activation in Oxidatively Stressed Cells and Tissues Using Biotinylated NAD Substrate

  2002influential reference
• Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

  2001influential reference
• Inhibition of poly (ADP‐ribose) synthetase by gene disruption or inhibition with 5‐iodo‐6‐amino‐1,2‐benzopyrone protects mice from multiple‐low‐dose‐streptozotocin‐induced diabetes

  2001cited by this paper
• Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase

  2001influential reference
• IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress.

  2001influential reference
• Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.

  2000cited by this paper
• Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.

  2000cited by this paper
• Myocardial Postischemic Injury Is Reduced by PolyADPribose Polymerase-1 Gene Disruption

  2000cited by this paper
• Myocardial Cell Death in Human Diabetes

  2000influential reference
• Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury.

  2000cited by this paper
• Protective effect of poly(ADP-ribose) polymerase inhibitors against cell damage induced by antiviral and anticancer drugs

  2000cited by this paper
• Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model.

  2000cited by this paper
• Physiological effects of peroxynitrite: potential products of the environment.

  2000cited by this paper
• Reducing the burden of diabetes: managing cardiovascular disease †

  1999cited by this paper
• Protection against hypoxia-reoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts.

  1999cited by this paper
• Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin

  1999cited by this paper
• Alterations of heart function and Na+-K+-ATPase activity by etomoxir in diabetic rats.

  1999cited by this paper
• Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants.

  1999cited by this paper
• Vascular function in Type 2 diabetes mellitus and pre‐diabetes: the case for intrinsic endotheliopathy

  1999cited by this paper
• Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.

  1999cited by this paper
• Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice

  1999cited by this paper
• Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes.

  1999cited by this paper
• An inhibitor of poly (ADP‐ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart

  1999cited by this paper
• Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway.

  1999cited by this paper
• Poly (ADP-ribose) polymerase, nitric oxide and cell death.

  1999cited by this paper
• Diabetic cardiomyopathy

  1998cited by this paper
• Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils

  1998cited by this paper
• Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig.

  1998cited by this paper
• Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury.

  1998cited by this paper
• Subcellular remodeling and heart dysfunction in chronic diabetes.

  1998cited by this paper
• Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase.

  1998cited by this paper
• What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?

  1997cited by this paper
• Inhibition of the activity of poly(ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle.

  1997cited by this paper
• Protection by inhibition of poly (ADP-ribose) synthetase against oxidant injury in cardiac myoblasts In vitro.

  1997cited by this paper
• Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase.

  1997cited by this paper
• Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1997cited by this paper
• Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.

  1997cited by this paper
• Oxidative damage to DNA in diabetes mellitus.

  1996cited by this paper
• Molecular mechanisms of beta-cell destruction in IDDM: the role of nicotinamide.

  1996cited by this paper
• Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus

  1995cited by this paper
• Diabetic Cardiomyopathy: A unique entity or a complication of coronary artery disease?

  1995cited by this paper
• Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells

  1995cited by this paper
• Diabetic cardiomyopathy: experimental and clinical observations.

  1994cited by this paper
• The diabetic heart: metabolic causes for the development of a cardiomyopathy.

  1992cited by this paper
• Anatomical and functional cardiac abnormalities in type I diabetes

  1992cited by this paper
• Diabetic Cardiomyopathy

  1990cited by this paper
• Cardiac dysfunction in isolated perfused hearts from spontaneously diabetic BB rats.

  1990cited by this paper
• A Functional and Ultrastructural Analysis of Experimental Diabetic Rat Myocardium: Manifestation of a Cardiomyopathy

  1985cited by this paper
• The Effect of Diabetes on Performance and Metabolism of Rat Hearts

  1980cited by this paper
• Downloaded from http://circres.ahajournals.org / by guest on February 23, 2013Peroxynitrite Is a Major Contributor to Cytokine-Induced

  year unknowncited by this paper

• Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies

  2025cites this paper
• Reductive stress: The key pathway in metabolic disorders induced by overnutrition

  2025cites this paper
• Pathogenesis and management of diabetic gastroparesis: An updated clinically oriented review.

  2024cites this paper
• HIF-1α serves as a co-linker between AD and T2DM.

  2024cites this paper
• ADP-ribosylation, a multifaceted modification: functions and mechanisms in aging and aging-related diseases.

  2024cites this paper
• A retrospective review of marine algae and the strategies employed for prospective diabetes management

  2023cites this paper
• The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy

  2023cites this paper
• Moringa oleifera: A Review on the Antiproliferative Potential in Breast Cancer Cells

  2023cites this paper
• Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes.

  2022cites this paper
• Ca2+ mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy

  2022cites this paper
• Mechanistic approach towards diabetic neuropathy screening techniques and future challenges: A review.

  2022cites this paper
• Drug repurposing - A search for novel therapy for the treatment of diabetic neuropathy.

  2022cites this paper
• Heart rate-corrected QT interval prolongation is associated with decreased heart rate variability in patients with type 2 diabetes

  2022cites this paper
• Protective Effect of Minocycline Hydrochloride on the Mouse Embryonic Development Against Suboptimal Environment

  2022cites this paper
• Exercise and Nutraceuticals: Eminent approach for Diabetic Neuropathy.

  2021cites this paper
• Diabetic Cardiovascular Autonomic Neuropathy

  2021cites this paper
• Diabetic Neuropathy: Review on Molecular Mechanisms.

  2021cites this paper
• Okamoto model for necrosis and its expansions, CD38-cyclic ADP-ribose signal system for intracellular Ca2+ mobilization and Reg (Regenerating gene protein)-Reg receptor system for cell regeneration

  2021cites this paper
• PARPs in lipid metabolism and related diseases.

  2021cites this paper
• Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages

  2021cites this paper
• Diabetes Mellitus Promotes Atrial Structural Remodeling and PARP-1/Ikkα/NF-κB Pathway Activation in Mice

  2021cites this paper
• The Protective Effects of Ropivacaine Against High Glucose-induced Brain Microvascular Endothelial Injury by Reducing MMPs and Alleviating Oxidative Stress

  2021cites this paper
• Role of Akt Activation in PARP Inhibitor Resistance in Cancer

  2020cites this paper
• Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.

  2020cites this paper
• PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells

  2019cites this paper
• Role of pseudohypoxia in the pathogenesis of type 2 diabetes

  2019cites this paper
• 1,4-dihidropiridīna atvasinājumu ietekme uz DNS reparācijas un proteolīzes enzīmu ekspresiju cukura diabēta modelī un DNS divpavedienu pārrāvumu līmeni in vitro

  2019cites this paper
• Ca

  2019cites this paper
• Histone Deacetylases and Oxidative Stress: Role in Diabetic Cardiomyopathy

  2019cites this paper
• Chronic Inhibition of Mitochondrial Dihydrolipoamide Dehydrogenase (DLDH) as an Approach to Managing Diabetic Oxidative Stress

  2019cites this paper
• Nitrosative Stress and Cardiogenesis: Cardiac Remodelling Perturbs Embryonic Metabolome

  2019cites this paper
• Water-soluble C60 fullerene ameliorates astroglial reactivity and TNFa production in retina of diabetic rats

  2019cites this paper
• HP_A_202775 33..40

  2019cites this paper
• Pupillary Abnormalities with Varying Severity of Diabetic Retinopathy

  2018cites this paper
• Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders

  2018cites this paper
• Diabetes and Cannabis: Myth or Reality

  2018cites this paper
• PARP‐1 inhibition protects the diabetic heart through activation of SIRT1‐PGC‐1&agr; axis☆

  2018cites this paper
• Of mice and men: models and mechanisms of diabetic cardiomyopathy

  2018cites this paper
• Metabolic and Biochemical Stressors in Diabetic Cardiomyopathy

  2017cites this paper
• CHAPTER 23 PERIPHERAL AND AUTONOMIC NEUROPATHY IN DIABETES

  2017cites this paper
• Oxidative Stress-Related Parthanatos of Circulating Mononuclear Leukocytes in Heart Failure

  2017cites this paper
• Poly ADP-ribose polymerase-1: Beyond transcription and towards differentiation.

  2017cites this paper
• Chronic PARP-1 inhibition reduces carotid vessel remodeling and oxidative damage of the dorsal hippocampus in spontaneously hypertensive rats

  2017cites this paper
• Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis

  2017cites this paper
• 1,25(OH)2D3 improves cardiac dysfunction, hypertrophy, and fibrosis through PARP1/SIRT1/mTOR‐related mechanisms in type 1 diabetes

  2017cites this paper
• Pancreatic mitochondrial complex I exhibits aberrant hyperactivity in diabetes

  2017cites this paper
• An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US

  2017cites this paper
• Quantification of PARP Activity in Human Tissues: Ex Vivo Assays in Blood Cells and Immunohistochemistry in Human Biopsies.

  2017cites this paper
• Polyploidy and nuclear phenotype characteristics of cardiomyocytes from diabetic adult and normoglycemic aged mice.

  2017cites this paper
• Targeting Mitochondrial Dysfunction for the Treatment of Diabetic Complications: Pharmacological Interventions through Natural Products

  2017cites this paper
• Diabetic Cardiomyopathy: An Immunometabolic Perspective

  2017cites this paper
• Metabolic remodelling in diabetic cardiomyopathy

  2017cites this paper
• PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals.

  2016cites this paper
• Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade

  2016cites this paper
• Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications

  2016cites this paper
• Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity.

  2016cites this paper
• Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart.

  2016cites this paper
• Regulators of Beta-Cell Death and Regeneration

  2016cites this paper
• Investigation of cadmium-induced apoptosis and the protective effect of N-acetylcysteine in BRL 3A cells.

  2016cites this paper
• Low-level laser therapy (904nm) can increase collagen and reduce oxidative and nitrosative stress in diabetic wounded mouse skin.

  2016cites this paper
• Cannabidiol attenuates cardiac dysfunction , oxidative stress , fibrosis , and inflammatory and cell death signaling pathways in diabetic cardiomyopathy

  2016cites this paper
• diabetic heart cardiac inotropic reserve in the streptozotocin-induced Deletion of thioredoxin-interacting protein improves

  2016cites this paper
• Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance.

  2016cites this paper
• Cardiac Autonomic Neuropathy in Type II Diabetes Mellitus Patients and its Association with the Age of the Patient, Duration of Disease and Glycemic Control.

  2016cites this paper
• Phytochemicals as Prototypes for Pharmaceutical Leads Towards Drug Development Against Diabetic Cardiomyopathy.

  2016cites this paper
• Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy

  2016cites this paper
• Animal Models of Diabetic Macrovascular Complications: Key Players in the Development of New Therapeutic Approaches

  2015cites this paper
• Protective effects of paeonol on cardiovascular complications in diabetes mellitus involves modulation of PI3K /Akt-GSK-3β signalling, regulation of protease-activated receptor-1 expressions and down-regulation of inflammatory mediators

  2015cites this paper
• Updating Experimental Models of Diabetic Cardiomyopathy

  2015cites this paper
• Concomitant diabetes mellitus and heart failure.

  2015cites this paper
• OXIDATÍV STRESSZ ÉS GESZTÁCIÓS DIABÉTESZ Horváth Eszter Mária Semmelweis Egyetem, Klinikai Kísérleti Kutató- és Humán Élettani Intézet, Budapest A gesztációs diabétesz mellitusz (GMD), mely a szénhidrátháztartás terhesség során felismert zavara, a terhességek átlagosan 2-6%-

  2015cites this paper
• Pathophysiological Role of Peroxynitrite Induced DNA Damage in Human Diseases: A Special Focus on Poly(ADP-ribose) Polymerase (PARP)

  2015cites this paper
• Halting the March of Painful Diabetic Neuropathy

  2015cites this paper
• Targeting caveolin-3 for the treatment of diabetic cardiomyopathy.

  2015cites this paper
• Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.

  2015influential citation
• Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management

  2015cites this paper
• Nuclear factor kappa B inhibition improves conductance artery function in type 2 diabetic mice

  2015cites this paper
• Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy.

  2015cites this paper
• Animal Models of Diabetic Cardiomyopathy

  2015cites this paper
• Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study

  2015cites this paper
• Cardiac NO signalling in the metabolic syndrome

  2015cites this paper
• Experimental diabetes in neonatal mice induces early peripheral sensorimotor neuropathy.

  2014cites this paper
• IMPACT OF OXIDATIVE STRESS IN DEVELOPMENT OF DIABETIC RETINOPATHY AND ANTIOXIDANTS AS TREATMENT OPTION

  2014cites this paper
• Oxidative Stress and Cardiovascular Disease in Diabetes

  2014cites this paper
• The Role of Glutamate Signalling In Diabetic Neuropathy

  2014cites this paper
• Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage

  2014cites this paper
• Efficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-Analysis

  2014cites this paper
• Duodenal‐jejunal bypass surgery on type 2 diabetic rats reduces the expression of matrix metalloproteinase‐9 and tissue inhibitor of matrix metalloproteinase‐1 in the thoracic aorta

  2014cites this paper
• NERVE AND MUSCLE ( LH WEIMER , SECTION EDITOR ) Diabetic Neuropathy : Mechanisms , Emerging Treatments , and Subtypes

  2014cites this paper
• Cerebrovascular Disease in Type 1 Diabetes: Role of Oxidative Stress

  2014influential citation
• [Clinical and prognostic significance of genetic markers in craniocerebral injury (Part III)].

  2014influential citation
• Ursolic acid prevents endoplasmic reticulum stress-mediated apoptosis induced by heat stress in mouse cardiac myocytes.

  2014cites this paper
• Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.

  2014cites this paper
• Resveratrol and Cerebral Arterioles during Type 1 Diabetes

  2014cites this paper
• Selective inhibition of human tankyrases

  2014cites this paper
• A new face of endocannabinoids in pharmacotherapy. Part II: role of endocannabinoids in inflammation-derived cardiovaascular diseases.

  2014cites this paper
• Peroxynitrite modified DNA presents better epitopes for anti-DNA autoantibodies in diabetes type 1 patients.

  2014cites this paper
• Energy adaptive response during parthanatos is enhanced by PD98059 and involves mitochondrial function but not autophagy induction.

  2014cites this paper
• ARRHYTMIC EVENTS IN TYPE 2 DIABETIC PATIENTS ON INSULIN THERAPY

  2014cites this paper
• The Roles of Thiamine in Myocardial Infarction Possible Genetic and Cellular Signaling Mechanisms

  2014cites this paper